An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.
Molecules
; 25(21)2020 Nov 07.
Article
in English
| MEDLINE | ID: covidwho-1305742
ABSTRACT
Malaria control relies heavily on the small number of existing antimalarial drugs. However, recurring antimalarial drug resistance necessitates the continual generation of new antimalarial drugs with novel modes of action. In order to shift the focus from only controlling this disease towards elimination and eradication, next-generation antimalarial agents need to address the gaps in the malaria drug arsenal. This includes developing drugs for chemoprotection, treating severe malaria and blocking transmission. Plasmodial kinases are promising targets for next-generation antimalarial drug development as they mediate critical cellular processes and some are active across multiple stages of the parasite's life cycle. This review gives an update on the progress made thus far with regards to plasmodial kinase small-molecule inhibitor development.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Plasmodium
/
Protein Kinase Inhibitors
/
Drug Discovery
/
Malaria
/
Antimalarials
Type of study:
Prognostic study
Limits:
Animals
/
Humans
Language:
English
Journal subject:
Biology
Year:
2020
Document Type:
Article
Affiliation country:
Molecules25215182
Similar
MEDLINE
...
LILACS
LIS